Literature DB >> 12232778

A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19.

R F Badenhop1, M J Moses, A Scimone, P B Mitchell, K R Ewen-White, A Rosso, J A Donald, L J Adams, P R Schofield.   

Abstract

Bipolar affective disorder is a severe mood disorder that afflicts approximately 1% of the population worldwide. Twin and adoption studies have indicated that genetic factors contribute to the disorder and while many chromosomal regions have been implicated, no susceptibility genes have been identified. We undertook a combined analysis of 10 cM genome screen data from a single large bipolar affective disorder pedigree, for which we have previously reported linkage to chromosome 13q14 (Badenhop et al, 2001) and 12 pedigrees independently screened using the same 400 microsatellite markers. This 13 pedigree cohort consisted of 231 individuals, including 69 affected members. Two-point LOD score analysis was carried out under heterogeneity for three diagnostic and four genetic models. Non-parametric multipoint analysis was carried out on regions of interest. Two-point heterogeneity LOD scores (HLODs) greater than 1.5 were obtained for 11 markers across the genome, with HLODs greater than 2.0 obtained for four of these markers. The strongest evidence for linkage was at 3q25-26 with a genome-wide maximum score of 2.49 at D3S1279. Six markers across a 50 cM region at 3q25-26 gave HLODs greater than 1.5, with three of these markers producing scores greater than 2.0. Multipoint analysis indicated a 20 cM peak between markers D3S1569 and D3S1614 with a maximum NPL of 2.8 (P = 0.004). Three other chromosomal regions yielded evidence for linkage: 9q31-q33, 13q14 and 19q12-q13. The regions on chromosomes 3q and 13q have previously been implicated in other bipolar and schizophrenia studies. In addition, several individual pedigrees gave LOD scores greater than 1.5 for previously reported bipolar susceptibility loci on chromosomes 18p11, 18q12, 22q11 and 8p22-23.

Entities:  

Mesh:

Year:  2002        PMID: 12232778     DOI: 10.1038/sj.mp.4001114

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  17 in total

1.  Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q.

Authors:  Matthew B McQueen; B Devlin; Stephen V Faraone; Vishwajit L Nimgaonkar; Pamela Sklar; Jordan W Smoller; Rami Abou Jamra; Margot Albus; Silviu-Alin Bacanu; Miron Baron; Thomas B Barrett; Wade Berrettini; Deborah Blacker; William Byerley; Sven Cichon; Willam Coryell; Nick Craddock; Mark J Daly; J Raymond Depaulo; Howard J Edenberg; Tatiana Foroud; Michael Gill; T Conrad Gilliam; Marian Hamshere; Ian Jones; Lisa Jones; Suh-Hang Juo; John R Kelsoe; David Lambert; Christoph Lange; Bernard Lerer; Jianjun Liu; Wolfgang Maier; James D Mackinnon; Melvin G McInnis; Francis J McMahon; Dennis L Murphy; Markus M Nothen; John I Nurnberger; Carlos N Pato; Michele T Pato; James B Potash; Peter Propping; Ann E Pulver; John P Rice; Marcella Rietschel; William Scheftner; Johannes Schumacher; Ricardo Segurado; Kristel Van Steen; Weiting Xie; Peter P Zandi; Nan M Laird
Journal:  Am J Hum Genet       Date:  2005-08-15       Impact factor: 11.025

Review 2.  Melatonin, circadian rhythms, and the clock genes in bipolar disorder.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

3.  Family-based association analysis of alcohol dependence in the COGA sample and replication in the Australian twin-family study.

Authors:  Ke-Sheng Wang; Xuefeng Liu; Nagesh Aragam; Xueqiu Jian; Jerald E Mullersman; Yali Liu; Yue Pan
Journal:  J Neural Transm (Vienna)       Date:  2011-03-29       Impact factor: 3.575

4.  A genome-wide association study of bipolar disorder and comorbid migraine.

Authors:  K J Oedegaard; T A Greenwood; S Johansson; K K Jacobsen; A Halmoy; O B Fasmer; H S Akiskal; J Haavik; J R Kelsoe
Journal:  Genes Brain Behav       Date:  2010-06-29       Impact factor: 3.449

Review 5.  Chronobiology of bipolar disorder: therapeutic implication.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-08       Impact factor: 5.285

6.  Linkage analysis of a completely ascertained sample of familial schizophrenics and bipolars from Palau, Micronesia.

Authors:  Lambertus Klei; Silviu-Alin Bacanu; Marina Myles-Worsley; Brandi Galke; Weiting Xie; Josepha Tiobech; Caleb Otto; Kathyrn Roeder; Bernie Devlin; William Byerley
Journal:  Hum Genet       Date:  2005-05-25       Impact factor: 4.132

Review 7.  GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.

Authors:  Michael K Rowe; Charlotte Wiest; De-Maw Chuang
Journal:  Neurosci Biobehav Rev       Date:  2007-03-15       Impact factor: 8.989

8.  Neuropsychological performance as endophenotypes in extended schizophrenia families from the Central Valley of Costa Rica.

Authors:  Hilary Bertisch; Andrea Mesen-Fainardi; Maureen V Martin; Vanessa Pérez-Vargas; Tatiana Vargas-Rodríguez; Gabriela Delgado; Camila Delgado; Michele Llach; Beatrice LaPrade; William Byerley; William E Bunney; Marquis P Vawter; Lynn E DeLisi
Journal:  Psychiatr Genet       Date:  2009-02       Impact factor: 2.458

9.  Genes in the serotonin pathway are associated with bipolar affective disorder in a Han Chinese population.

Authors:  Bo Xiang; Zhenxing Yang; Yin Lin; Lijie Guan; Xuan Li; Wei Deng; Zeyu Jiang; Guohui Lao; Qiang Wang; Xiaoyu Hao; Xiang Liu; Yingcheng Wang; Liansheng Zhao; Xiaohong Ma; Tao Li; Liping Cao; Xun Hu
Journal:  Neurosci Bull       Date:  2013-10-17       Impact factor: 5.203

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder.

Authors:  Ricardo Segurado; Sevilla D Detera-Wadleigh; Douglas F Levinson; Cathryn M Lewis; Michael Gill; John I Nurnberger; Nick Craddock; J Raymond DePaulo; Miron Baron; Elliot S Gershon; Jenny Ekholm; Sven Cichon; Gustavo Turecki; Stephan Claes; John R Kelsoe; Peter R Schofield; Renee F Badenhop; J Morissette; Hilary Coon; Douglas Blackwood; L Alison McInnes; Tatiana Foroud; Howard J Edenberg; Theodore Reich; John P Rice; Alison Goate; Melvin G McInnis; Francis J McMahon; Judith A Badner; Lynn R Goldin; Phil Bennett; Virginia L Willour; Peter P Zandi; Jianjun Liu; Conrad Gilliam; Suh-Hang Juo; Wade H Berrettini; Takeo Yoshikawa; Leena Peltonen; Jouko Lönnqvist; Markus M Nöthen; Johannes Schumacher; Christine Windemuth; Marcella Rietschel; Peter Propping; Wolfgang Maier; Martin Alda; Paul Grof; Guy A Rouleau; Jurgen Del-Favero; Christine Van Broeckhoven; Julien Mendlewicz; Rolf Adolfsson; M Anne Spence; Hermann Luebbert; Linda J Adams; Jennifer A Donald; Philip B Mitchell; Nicholas Barden; Eric Shink; William Byerley; Walter Muir; Peter M Visscher; Stuart Macgregor; Hugh Gurling; Gursharan Kalsi; Andrew McQuillin; Michael A Escamilla; Victor I Reus; Pedro Leon; Nelson B Freimer; Henrik Ewald; Torben A Kruse; Ole Mors; Uppala Radhakrishna; Jean-Louis Blouin; Stylianos E Antonarakis; Nurten Akarsu
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.